In vitro interleukin-5 (IL-5) production by peripheral blood mononuclear cells from patients with drug hypersensitivity

Journal of Dermatology

Volumn 23, Issue 6, 1996, Pages 377-381

  Mikami, Chikage ^a   Ochiai, Kenichi ^a   Kagami, Masaru ^a   Tomioka, Hisao ^a   Tanabe, Emiko ^a  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CD4+ T lymphocytes; drug hypersensitivity; eosinophilia; interleukin 5 (IL 5)

Indexed keywords

INTERLEUKIN 5;

ARTICLE; CONTROLLED STUDY; DRUG HYPERSENSITIVITY; EOSINOPHILIA; HELPER CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LYMPHOCYTIC INFILTRATION; MONONUCLEAR CELL; RASH; SUPPRESSOR CELL; ADULT; AGED; BIOSYNTHESIS; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; DRUG ERUPTION; ENZYME IMMUNOASSAY; EOSINOPHIL; FEMALE; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; AGED; CD4-CD8 RATIO; CD4-POSITIVE T-LYMPHOCYTES; DRUG ERUPTIONS; EOSINOPHILIA; EOSINOPHILS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INTERLEUKIN-5; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED;

EID: 0030163455     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.1996.tb04037.x     Document Type: Article

References (24)

1. Tone T, Nishioka K, Kameyama K, Asahi T, Takezaki S, Nishiyama S: Common histopathological processes of phenytoin drug eruption, J Dermatol (Tokyo), 19: 27-34, 1992.
2. Nakajima H, Iwamoto I, Tomoe S, et al: CD4+ T lymphocytes and interleukin-5 mediate antigen-in-duced eosinophil infiltration into the mouse trachea, Am Rev Respir Dis, 144: 374-377, 1992.
3. Kay AB, Ying S, Varney V, et al: Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced latephase cutaneous reactions in atopic subjects, J Exp Med, 173: 775-778, 1991.
4. Durham SR Ying S, Varney V, et al: Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocytes/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: Relationship to tissue eosinophilia, J Immunol, 148: 2390-2394, 1992.
5. Lopez AF, Sanderson CJ, Gamble JR, Campbell HD, Young IG, Vadas MA: Recombinant human interleukin-5 is a selective activator of human eosinophil function, J Exp Med, 167: 219-224, 1988.
6. Yamaguchi Y, Hayashi Y, Sugama Y, et al: Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor, J Exp Med, 167: 1737-1742, 1988.
7. Walsh GM, Harnell A, Wardlaw AJ, Krihara K, Sanderson CJ, Kay AB: IL-5 enhances the in vitro adhesion of human eosinophils but not neutrophils in a leukocyte integrin (CD11/18)-dependent manner, Immunology, 71: 258-265, 1990.
8. Robinson D, Hamid Q, Bentley A, Ying S, Kay AB, Durham SR: Activation of CD4+ T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma, J Allergy Clin Immunol, 92: 313-324, 1993.
9. Dobozy A, Hunyadi J, Enderessy ASZ, Simon N: Lymphocyte transformation test in detection of drug hypersensitivity, Clin Exp Dermatol, 6: 367-372,1981.
10. Hsu SM, Raine L, Fanger H: Use of avidin-biotinperoxidase complex (ABC) on immunoperoxidase techniques, a comparison between ABC and unlabeled (PAP) procedures, J Histochem Cytochem, 29: 577,1981.
11. Mosmann T, Coffman RL: TH1 and TH2 cells: Different patterns of lymphokine selection lead to different functional properities, Annu Rev Immunol, 7: 145-173, 1989.
12. Endo H, Iwamoto I, Nakajima H, Yoshida S: In vitro interleukin-5 production of peripheral blood mononuclear cells is increased in patients with asthma, Int Arch Allergy Immunol, 101: 425-430, 1993.
13. Lamas AM, Mulroney CR, Schleimer RP: Studies on the adhesive interaction between human eosinophils and cultured vascular endothelial cells, J Exp Med, 140: 1500-1505, 1988.
14. Fujisawa T, Abu-Ghazaleh R, Kita H, Sanderson CJ, Gleich GJ: Regulatory effect of cytokines on eosinophil degranulation,J Immunol, 144: 642-646, 1990.
15. Tsutsui H, Terano Y, Sakagami C, Hasegawa I, Mizoguchi Y, Morisawa S: Drug-specific T cells derived from patients with drug-induced allergic hepatitis, J Immunol, 149: 706-716, 1992.
16. Shelley WG: Indirect basophil degranulation test for allergy to penicillin and other drugs, J Am Med Assoc, 184: 171-178, 1963.
17. Thiel JA, Mitchell S, Parker CW: The specificity of hemagglutination reactions in human and experimental penicillin hypersensitivity, J Allergy, 35: 399-424, 1964.
18. Dascale DI, Kletter Y, Baratz M, Brenner S: Langerhans cell distribution in drug eruption, Acta Derm Venereol (Stockh), 72: 175-177, 1992.
19. Pohl LR, Satoh H, Christ DD, Kenna JG: The immunologic and metabolic basis of drug hypersensitivities, Ann Rev Pharmacol, 28: 367-387, 1988.
20. Wintroub BU, Stern R: Cutaneous drug reaction; Pathogenesis and clinical classification, J Am Acad Dermatol, 13: 167-179, 1985.
21. Chisholm DM, Mason DK: Labial salivary gland biopsy in Sjögren's disease, J Clin Path, 21: 661-667, 1968.
22. Stewart CC, Cramer SF, Steward PG: The response of human peripheral blood lymphocytes to phytohemagglutinin: Determination of cell numbers, Cellular Immunology, 16: 237-250, 1975.
23. David JR, Al-Askari S, Lawrence HS, Thomas L: Delayed hypersensitivity in vitro, 1, The specificity of inhibition of cell migration by antigens, J Immunol, 93: 264, 1964.
24. Kitami N, Yamaguchi K: Diagnosis of drug allergy using peripheral blood lymphocytes, Rinsyo Meneki, 15: 727-736, 1983. (in Japanese)